Charles River Laboratories International Inc (CRL)
195.77
+1.58
(+0.81%)
USD |
NYSE |
Nov 22, 16:00
195.80
+0.03
(+0.02%)
After-Hours: 20:00
Charles River Laboratories International Market Cap: 10.01B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 10.01B |
| November 21, 2024 | 9.930B |
| November 20, 2024 | 9.608B |
| November 19, 2024 | 9.516B |
| November 18, 2024 | 9.588B |
| November 15, 2024 | 9.600B |
| November 14, 2024 | 10.07B |
| November 13, 2024 | 10.56B |
| November 12, 2024 | 11.04B |
| November 11, 2024 | 11.29B |
| November 08, 2024 | 11.01B |
| November 07, 2024 | 10.75B |
| November 06, 2024 | 10.95B |
| November 05, 2024 | 9.648B |
| November 04, 2024 | 9.331B |
| November 01, 2024 | 9.254B |
| October 31, 2024 | 9.132B |
| October 30, 2024 | 9.276B |
| October 29, 2024 | 9.409B |
| October 28, 2024 | 9.538B |
| October 25, 2024 | 9.313B |
| October 24, 2024 | 9.344B |
| October 23, 2024 | 9.543B |
| October 22, 2024 | 9.508B |
| October 21, 2024 | 9.973B |
| Date | Value |
|---|---|
| October 18, 2024 | 10.11B |
| October 17, 2024 | 10.11B |
| October 16, 2024 | 9.977B |
| October 15, 2024 | 9.913B |
| October 14, 2024 | 9.876B |
| October 11, 2024 | 9.867B |
| October 10, 2024 | 9.789B |
| October 09, 2024 | 9.598B |
| October 08, 2024 | 9.553B |
| October 07, 2024 | 9.676B |
| October 04, 2024 | 9.753B |
| October 03, 2024 | 9.694B |
| October 02, 2024 | 9.864B |
| October 01, 2024 | 9.924B |
| September 30, 2024 | 10.07B |
| September 27, 2024 | 10.24B |
| September 26, 2024 | 10.24B |
| September 25, 2024 | 9.960B |
| September 24, 2024 | 10.36B |
| September 23, 2024 | 10.52B |
| September 20, 2024 | 10.63B |
| September 19, 2024 | 10.82B |
| September 18, 2024 | 10.64B |
| September 17, 2024 | 10.65B |
| September 16, 2024 | 10.52B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.894B
Minimum
Mar 18 2020
23.10B
Maximum
Sep 24 2021
12.23B
Average
11.21B
Median
Market Cap Benchmarks
| Boston Scientific Corp | 132.64B |
| CVS Health Corp | 73.00B |
| Arbutus Biopharma Corp | 665.12M |
| FibroBiologics Inc | 90.11M |
| Biomarin Pharmaceutical Inc | 12.25B |
Market Cap Related Metrics
| PE Ratio | 24.44 |
| PS Ratio | 2.490 |
| Price to Book Value | 2.647 |
| Price to Free Cash Flow | 18.04 |
| Price | 195.77 |
| Earnings Yield | 4.09% |
| Operating PE Ratio | 19.15 |
| Normalized PE Ratio | 24.44 |